Trade Summary

6 days ago, Coughlin Timothy, serving as Dir at Travere Therapeutics, Inc. (TVTX), sold 3,250 shares at $43.49 per share, for a total transaction value of $141,343.00. Following this transaction, Coughlin Timothy now holds 52,250 shares of TVTX.

This sale represents a 6.00% decrease in Coughlin Timothy's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 4:05 PM ET, 4 days after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.